Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Continual obstructive pulmonary illness (COPD) is a continual inflammatory lung illness characterised by coughing, the manufacturing of extra sputum, and dyspnea. Sufferers with excessively thick sputum could have frequent assaults or develop extra severe illness. The rules advocate airway clearance for sufferers with extreme sputum who’re hospitalized with COPD. The lively cycle of respiratory approach is the commonest non-pharmacological airway clearance approach utilized by physiotherapists. Nevertheless, the effectiveness of the approach shouldn’t be at all times assured. Energetic cycle of respiratory methods require the preliminary dilution of the sputum, normally by inhalation medicine, which can have restricted results.
 We suggest a single-blind randomized managed trial utilizing 75 hospitalized sufferers recognized with COPD with extreme sputum manufacturing. The sufferers might be divided into three teams. The intervention group will obtain lively cycle of respiratory methods mixed with phonophoresis. The 2 comparability teams might be handled with lively cycle of respiratory methods and phonophoresis, respectively. This system might be applied day by day for 1 week. The first outcomes might be adjustments in sputum viscosity and manufacturing, lung operate, and pulse oximetry.
Secondary outcomes embody the evaluation of COPD and anxiousness, measured by the COPD Evaluation Take a look at scale and the Nervousness Stock for Respiratory Illness, respectively; self-satisfaction; the diploma of cooperation; and the size of hospital keep. All final result measures, except for sputum manufacturing and extra secondary outcomes, might be assessed on the graduation of the examine and after 1 week’s intervention. Evaluation of variance might be used to research variations between the teams, and a p-value of lower than 0.05 (two-tailed) might be thought-about statistically vital.
Current research have discovered that phonophoresis decreases irritation, suggesting the potential of the mixed utilization of lively cycle of respiratory methods and phonophoresis. Subsequently, the intention of this examine is to discover the effectiveness and security of mixing lively cycle of respiratory approach and phonophoresis in treating COPD sufferers. This examine introduces a mixture of lively cycle of respiratory methods and phonophoresis to discover the affect of those interventions on sufferers hospitalized with COPD. If this mixed intervention is proven to be efficient, it could show to be a greater therapy for sufferers with COPD.

The impact of consecutive ambient air air pollution on the hospital admission from continual obstructive pulmonary illness within the Chengdu area, China

Hospitalisation dangers for continual obstructive pulmonary illness (COPD) have been attributed to ambient air air pollution worldwide. Nevertheless, an increase in COPD hospitalisations could point out a substantial enhance in fatality charge in public well being. The present examine focuses on the affiliation between consecutive ambient air air pollution (CAAP) and COPD hospitalisation to supply predictable early steering in the direction of estimates of COPD hospital admissions within the occasion of consecutive publicity to air air pollution.

Massive knowledge analytics had been collected from 3-year time collection recordings (from 2015 to 2017) of each air knowledge and COPD hospitalisation knowledge within the Chengdu area in China. Based mostly on the mixed results of CAAP and unit enhance in air pollutant concentrations, a quasi-Poisson regression mannequin was established, which revealed the affiliation between CAAP and estimated COPD admissions. The outcomes present the dynamics and outbreaks within the variations in COPD admissions in response to CAAP. Cross-validation and imply squared error (MSE) are utilized to validate the goodness of match.

In each short-term and long-term air air pollution exposures, Z check outcomes present that the COPD hospitalisation threat is larger for males than for ladies; equally, the prevalence of COPD hospital admissions within the group of aged individuals (> 65 years outdated) is considerably bigger than that in decrease age teams. The time lag between the air high quality and COPD hospitalisation can also be investigated, and a peak of COPD hospitalisation threat is discovered to lag 2 days for air high quality index (AQI) and PM10, and 1 day for PM2.5. The massive data-based predictive paradigm could be a measure for the early detection of a public well being occasion in post-COVID-19. The examine findings also can present steering for COPD admissions within the occasion of consecutive publicity to air air pollution within the Chengdu area.

Role of the active cycle of breathing technique combined with phonophoresis for the treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a preliminary randomized controlled trial

Harnessing cell well being know-how to help lengthytime period continual sickness administration: exploring household caregiver help wants within the outpatient setting

 Household caregiving is a crucial public well being subject, significantly with the getting old inhabitants. Lately, cell well being (mHealth) know-how has emerged as a possible low-cost, scalable platform to handle caregiver help wants, and thereby alleviate the burden on caregivers. This examine sought to look at the help wants of household caregivers of their lived experiences of outpatient care to tell the event of a future mHealth intervention. We performed 20 semi-structured interviews in 2 outpatient hematopoietic cell transplant (HCT) clinics at a big tutorial medical heart within the Midwestern United States. A thematic evaluation was carried out to outline rising themes.
Qualitative knowledge evaluation recognized 5 main themes that HCT caregivers confronted: (I) life-style restrictions as a result of affected person’s immunocompromised state; (II) Unmet wants attributable to limitations within the present assets, together with unfamiliar medical duties with out crucial trainings; and (III) caregivers’ adaptive methods, together with reformation of social relationships with household and buddies. Based mostly on these findings, we recommend Three design issues to information the event of a future mHealth intervention.

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E02C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E02C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E06C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Goat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E08C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E07C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A12043 96T
EUR 700
Description: ELISA

Canine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A64387 96T
EUR 700
Description: ELISA

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A29522 96T
EUR 700
Description: ELISA

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E04C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Rabbit Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E03C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A73101 96T
EUR 700
Description: ELISA

Sheep Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A99249 96T
EUR 700
Description: ELISA

Bovine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A81820 96T
EUR 700
Description: ELISA

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E09C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Monkey Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A20784 96T
EUR 700
Description: ELISA

Porcine Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A55672 96T
EUR 700
Description: ELISA

Chicken Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A90543 96T
EUR 700
Description: ELISA

Guinea Pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E01A38237 96T
EUR 700
Description: ELISA

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) ELISA kit

E05C1802-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Guinea pig Chronic lymphocytic leukemia up regulated protein 1(CLLU1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Chronic lymphocytic leukemia up-regulated protein 1 (CLLU1) ELISA Kit

abx507323-96tests 96 tests
EUR 687.5

CLLU1 (untagged)-Human chronic lymphocytic leukemia up-regulated 1 (CLLU1)

SC302372 10 µg Ask for price

CLLU1 (GFP-tagged) - Human chronic lymphocytic leukemia up-regulated 1 (CLLU1)

RG220420 10 µg Ask for price

CLLU1 (Myc-DDK-tagged)-Human chronic lymphocytic leukemia up-regulated 1 (CLLU1)

RC220420 10 µg Ask for price

CLLU1OS (untagged)-Human chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS)

SC302371 10 µg Ask for price

Lenti ORF clone of Human chronic lymphocytic leukemia up-regulated 1 (CLLU1), mGFP tagged

RC220420L4 10 µg Ask for price

CLLU1OS (GFP-tagged) - Human chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS)

RG212117 10 µg Ask for price

Lenti ORF clone of Human chronic lymphocytic leukemia up-regulated 1 (CLLU1), Myc-DDK-tagged

RC220420L3 10 µg Ask for price

Human Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein (CLLU1-AS1) ELISA Kit

abx507403-96tests 96 tests
EUR 687.5

CLLU1OS (Myc-DDK-tagged)-Human chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS)

RC212117 10 µg Ask for price

Chronic Lymphocytic Leukemia Deletion Region Gene 8 Protein (CLLD8) Antibody

abx430501-200ul 200 ul
EUR 460.8

Chronic Lymphocytic Leukemia Deletion Region Gene 8 Protein (CLLD8) Antibody

abx430501-200l 200 µl
EUR 387.5

Lenti ORF clone of Human chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS), mGFP tagged

RC212117L4 10 µg Ask for price

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 0.2mg/mL

BNUB2035-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 0.2mg/mL

BNUB2035-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 0.2mg/mL

BNUB2046-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 0.2mg/mL

BNUB2046-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), 0.2mg/mL

BNUB2047-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), 0.2mg/mL

BNUB2047-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 1mg/mL

BNUM2035-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL

BNUM2046-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), 1mg/mL

BNUM2047-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNUB2035-50 50uL
EUR 486
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), 1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNUB2046-50 50uL
EUR 486
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), 1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC702035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC702046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC802035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC802046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC812035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC812046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC552035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC552046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF555 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC612035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC612046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF660R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC432035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC432046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF543 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNC052035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNC052046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCA2035-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCA2046-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), APC conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCAP2035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCAP2046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCH2035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCH2046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCP2035-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCP2046-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), PerCP conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody

BNCR2035-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), RPE conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody

BNCR2046-250 250uL
EUR 472.8
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), RPE conjugate, Concentration: 0.1mg/mL

Lenti ORF particles, CLLU1 (mGFP-tagged) - Human chronic lymphocytic leukemia up-regulated 1 (CLLU1), 200ul, >10^7 TU/mL

RC220420L4V 200 µl Ask for price

Lenti ORF clone of Human chronic lymphocytic leukemia up-regulated 1 opposite strand (CLLU1OS), Myc-DDK-tagged

RC212117L3 10 µg Ask for price

Lenti ORF particles, CLLU1 (Myc-DDK tagged) - Human chronic lymphocytic leukemia up-regulated 1 (CLLU1), 200ul, >10^7 TU/mL

RC220420L3V 200 µl Ask for price

Anti-ZAP70 (Chronic Lymphocytic Leukemia Marker) Monoclonal Antibody

M00754-1 100ug/vial
EUR 476.4
Description: Mouse Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody. Validated in IHC and tested in Human.

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: 2F3.2

APR14717G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone 2F3.2. This antibody is applicable in IHC, IF, FC

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.1 0.1 ml
EUR 60.07

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C.5 0.5 ml
EUR 200.66

ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Concentrate)

RA0453-C1 1 ml
EUR 361.66

Monoclonal ZAP70 (Chronic Lymphocytic Leukemia Marker) Antibody, Clone: SPM362

APR14716G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human ZAP70 (Chronic Lymphocytic Leukemia Marker). The antibodies are raised in Mouse and are from clone SPM362. This antibody is applicable in IHC, IF, FC

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, 0.1mg/mL

BNC682035-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF568 conjugate, 0.1mg/mL

BNC682035-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, 0.1mg/mL

BNC682046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, 0.1mg/mL

BNC682046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), CF568 conjugate, 0.1mg/mL

BNC682047-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), CF568 conjugate, 0.1mg/mL

BNC682047-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, 0.1mg/mL

BNC472035-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF647 conjugate, 0.1mg/mL

BNC472035-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, 0.1mg/mL

BNC472046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF647 conjugate, 0.1mg/mL

BNC472046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), CF647 conjugate, 0.1mg/mL

BNC472047-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker)(ZAP70/2047), CF647 conjugate, 0.1mg/mL

BNC472047-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, 0.1mg/mL

BNC942035-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF594 conjugate, 0.1mg/mL

BNC942035-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application
The findings herein captured the household caregiver’s lived experiences throughout outpatient care. There was broad settlement that caregiving was difficult and disturbing. Thus, efficient and scalable interventions to help caregivers are wanted. This examine offered knowledge to information the content material and design of a future mHealth intervention within the outpatient setting.